Inspira’s ART100 Clears Clinical Evaluation, Enters Procurement at Top U.S. Hospital

Event summary

  • Inspira’s ART100 system completed clinical evaluation at a leading U.S. academic medical center after treating ~30 patients across multiple indications.
  • The system transitioned from pilot use to standard clinical workflow, with no remaining open clinical evaluation phase.
  • The medical center initiated a budgeted procurement process for multiple ART100 systems, subject to procedural budget release.
  • This marks the first instance at a major U.S. academic medical center where the ART100 progressed from clinical evaluation to formal procurement.

The big picture

Inspira’s ART100 system has moved beyond pilot use to standard clinical workflow at a top U.S. academic medical center, marking a significant validation of its technology. This milestone strengthens Inspira’s U.S. commercial positioning and could support broader adoption across leading healthcare institutions. The transition from clinical evaluation to procurement highlights the growing acceptance of innovative life-support technologies in critical care settings.

What we're watching

Procurement Timing
The pace at which the budgeted procurement process advances will indicate the medical center’s commitment to integrating the ART100 into standard workflow.
Clinical Adoption
Whether the ART100’s success at this institution can be replicated at other top U.S. hospitals will determine its broader commercial viability.
Competitive Positioning
How Inspira leverages this milestone to differentiate itself in the competitive life-support and diagnostic technologies market.